4.8 Article

Homeostasis and transitional activation of regulatory T cells require c-Myc

Journal

SCIENCE ADVANCES
Volume 6, Issue 1, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aaw6443

Keywords

-

Funding

  1. U.S. NIH [NIH AI105887, AI131703, AI140761, AI150241, AI150514, CA221290]

Ask authors/readers for more resources

Regulatory T cell (T-reg) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of T-reg accumulation and functional activation. Myc activity is enriched in T-regs generated during neonatal life and responding to inflammation. Myc-deficient T-regs show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in T-regs results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4(+) and CD8(+) T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, T-re(g)-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired T-reg function and maturation. Thus, Myc coordinates T-reg accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available